Genmab A/S
Utility Patent Applications
Last updated:
List of all Genmab A/S patents 64 in total
| Status | Patent |
|---|---|
Application | Utility: BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF Filling date: 7 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: MODULATION OF COMPLEMENT-DEPENDENT CYTOTOXICITY THROUGH MODIFICATIONS OF THE C-TERMINUS OF ANTIBODY HEAVY CHAINS Filling date: 7 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: HUMANIZED OR CHIMERIC CD3 ANTIBODIES Filling date: 7 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS Filling date: 7 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: AGONISTIC TNF RECEPTOR BINDING AGENTS Filling date: 7 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: MONOCLONAL ANTIBODIES AGAINST C-MET Filling date: 7 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 Filling date: 7 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: PRODUCTION OF HETERODIMERIC PROTEINS Filling date: 7 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: VARIANTS OF CD38 ANTIBODY AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: MULTISPECIFIC ANTIGEN-BINDING MOLECULE WITH IMPROVED INTERNALIZATION CHARACTERISTICS Filling date: 7 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR Filling date: 7 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: HUMANIZED OR CHIMERIC CD3 ANTIBODIES Filling date: 7 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: ANTIBODIES BINDING AXL Filling date: 7 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: NEW DOSAGE REGIMENS FOR ANTIBODY DRUG CONJUGATES BASED ON ANTI-AXL ANTIBODIES Filling date: 7 Sep 2025 Issue date: 1 Aug 2019 |
Showing 50 to 64 of 64 patents.